IRR
Healthcare
Temasek tastes a lemon while True North makes a forgettable PE exit
Homegrown private equity firm True North and Singaporean sovereign wealth fund Temasek are exiting a healthcare ......
Healthcare
How is TPG faring in its second Indian pharma bet?
TPG Growth, the mid-market and growth equity platform of TPG, has pressed the sell button on what was the private ......
Finance
Amicus signing off from seven-year-old portfolio firm with a dud
Mid-market private equity firm Amicus Capital–started a decade ago by former True North partner Sunil Vasudevan, who ......
Consumer
100Unicorns earns windfall gains in exit from nutrition brand
Early-stage venture capital firm 100Unicorns has logged an exit from a nutrition brand after holding the investment for ......
Finance
Temasek scripting a double jackpot from decade-old India bet
Temasek, one of the two sovereign funds of the Singapore government that has been active in India along with its ......
Infrastructure
Singapore's GIC spins a jackpot from three-year-old India bet
Singapore sovereign wealth fund GIC, one of the largest international institutional investors in India with its ......
Finance
How a single bet is helping Chiratae Ventures pull out half of its third fund's corpus
Venture capital firm Chiratae Ventures has made an exit move from a company it first backed from its third fund ......
TMT
How did Creador's full exit from India tech portfolio pan out?
Creador, the South- and Southeast Asia-focused private equity firm founded by Brahmal Vasudevan, has sold its entire ......
Consumer
SoftBank sitting on modest gains from Oyo parent but Lightspeed, Peak XV strike gold
Japanese investment behemoth SoftBank will likely be sitting on modest gains on its billion-dollar bet on Oravel Stays ......
Infrastructure
SoftBank logs another exit move in India. How did it fare?
Japanese investment giant SoftBank, which makes private equity-style bets on technology-focused companies and harvested......
